跳至主要内容
临床试验/NCT01753050
NCT01753050Unknown不适用

A Quality Improvement Project for Goal-directed Intraoperative Hemodynamic Optimization in Patients Redo Hip Surgery

Charite University, Berlin, Germany2 个研究点 分布在 1 个国家目标入组 390 人开始时间: 2012年12月最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
390
试验地点
2
主要终点
postoperative complications

研究概览

简要总结

Several studies have demonstrated that goal-directed fluid therapy during high- risk-surgery reduces morbidity and length of hospital stay. This quality improvement is design to evaluate the implementation of an intraoperative goal-directed therapy, using a pulse contour analysis monitor to optimize the stroke volume, in patients undergoing redo-hip-surgery. The primary combined endpoints will be the incidence of postoperative complications and the secondary endpoints will be the decrease of hospital length of stay, length of ICU stay and hospital postoperative mortality. We amended another 130 patients getting crystalloid fluids in the hemodynamic optimization protocol.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients undergoing redo hip surgery
  • age above 18 years
  • signed informed consent

排除标准

  • urgent or emergency surgery

研究组 & 干预措施

Standard care

No Intervention

No specific hemodynamic optimization measures

Hemodynamic optimization

Experimental

Hemodynamic optimization by stroke volume monitoring

干预措施: Stroke volume monitoring (Device)

结局指标

主要结局

postoperative complications

时间窗: 30days

次要结局

  • length of hospital and ICU stay(30days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sascha Treskatsch

Dr.

Charite University, Berlin, Germany

研究点 (2)

Loading locations...

相似试验

HIP Surgery - Hemodynamic Optimization Project | 临床试验